DiagnosTear
Screening and Monitoring Kit for Dry Eye Syndrome
StartupDiagnosTear is a Tel Aviv-Yafo-based startup in the Health Tech & Life Sciences sector, established in 2013. Screening and Monitoring Kit for Dry Eye Syndrome. The company has raised a total of $4.55M across 4 funding rounds, currently at the Public stage. DiagnosTear was founded by Eran Eilat. Key investors include Elcam Medical, BIOLIGHT Life Sciences. The company has 1-10 employees.
With $4.55M in total funding, DiagnosTear is a Public-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Clinical Trial. The company holds 1 patent.
- StagePublic
- ProductClinical Trial
- ModelB2B
- Employees1-10
- HQTel Aviv-Yafo
- DistrictCenter District
- Last Round$700K
- Elcam Medical
- BIOLIGHT Life Sciences
Eran EilatFounder & CEO
10 articles covered by sources including finance.yahoo.com,
www.tipranks.com,
www.biospace.com,
www.sponser.co.il,
www.prnewswire.com.
What does DiagnosTear do?
DiagnosTear specializes in technology for the diagnosis and treatment of dry eye syndrome. The company is developing an assay designed to facilitate the diagnosis, treatment, and monitoring of dry eye syndrome by examining certain parameters in tear fluid. DiagnosTears TeaRx assay is based on various reagents that create color reactions when coming into contact with tear film, allowing for a semi-quantitative assessment of the parameters that define the syndrome. Information on the parameters assists in the diagnosis of the syndrome and enables a better, more informed selection of treatment and monitoring options. TeaRx enables the monitoring and screening of the condition by examining up to five different varieties of tear fluid. The test is carried out through the use of a simple device that is placed under the lower eyelid to absorb the tear fluid. DiagnosTear is an XLVision Sciences company and a fully owned subsidiary of BioLight.
How much funding has DiagnosTear raised?
DiagnosTear has raised $4.55M in total funding across 4 rounds. The company is currently at the Public stage. Key investors include Elcam Medical, BIOLIGHT Life Sciences.
Who founded DiagnosTear?
DiagnosTear was founded in 2013 by Eran Eilat (Founder & CEO).
What sector is DiagnosTear in?
DiagnosTear operates in Health Tech & Life Sciences, Medical Devices, Diagnostics Devices. Target customers: Healthcare & Life Sciences, Healthcare, Providers.
Where is DiagnosTear located?
DiagnosTear is based in Kiryat Atidim, Tel Aviv-Yafo, Israel, Center District.